August 21, 2019Open Access
Neoantigen quality, not quantity
Key Points
Key points are not available for this paper at this time.
Abstract
Prioritizing expressed clonal neoantigens in genes required for cancer cell survival may reduce the likelihood of resistance to neoantigen therapies.